YK-4-279 Induces Osteosarcoma Cell Cycle Arrest, DNA Damage Response, and Apoptosis by Regulating the MAPK Cascade
Weifeng Wang, Yuli Zhang, Xiuqin Jia, Liren Han, Ming Xin · 2025
Read YK-4-279 Induces Osteosarcoma Cell Cycle Arrest, DNA Damage Response, and Apoptosis by Regulating the MAPK Cascade by Weifeng Wang, Yuli Zhang, Xiuqin Jia, Liren Han, Ming Xin (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12753861.txt.
Description
A drug candidate halts bone cancer cells by waking stress signals, Weifeng Wang and co-authors report in a 2025 study. Osteosarcoma strikes mostly teens and lacks good drug options. The team dosed cultured cancer cells with the compound and tracked growth, division, and death.
Viability and growth fell, cells froze late in their cycle, and DNA damage plus death rose. A key signaling cascade switched on, raising activity in three of its arms. Blocking one arm partly undid the drug's effects, proving the cascade carries much of the punch. The work supports trials of the compound against a cancer that badly needs new weapons.
Catalog record
| CREATOR | Weifeng Wang, Yuli Zhang, Xiuqin Jia, Liren Han, Ming Xin |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 49 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |